INNZ MEDICAL ApS — Credit Rating and Financial Key Figures
CVR number: 34490805
Hohøje 110, 9500 Hobro
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 218.41 | 2 493.65 | 3 433.63 | 3 649.54 | 3 132.03 |
| Employee benefit expenses | -2 098.79 | -2 465.32 | -2 607.09 | -2 820.63 | -2 947.61 |
| Total depreciation | -0.99 | -0.67 | |||
| EBIT | 118.62 | 28.32 | 826.54 | 828.91 | 183.76 |
| Other financial income | 0.08 | ||||
| Other financial expenses | -14.88 | -48.63 | -28.59 | -73.03 | - 234.98 |
| Pre-tax profit | 103.74 | -20.31 | 797.95 | 755.88 | -51.14 |
| Income taxes | -26.12 | -2.62 | - 181.70 | - 183.61 | -41.81 |
| Net earnings | 77.62 | -22.93 | 616.25 | 572.27 | -92.95 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 39.33 | ||||
| Tangible assets total | 39.33 | ||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 1 103.80 | 1 837.13 | 2 185.00 | 2 050.00 | 3 516.00 |
| Inventories total | 1 103.80 | 1 837.13 | 2 185.00 | 2 050.00 | 3 516.00 |
| Current trade debtors | 1 361.93 | 1 448.56 | 3 166.71 | 1 505.04 | 1 727.80 |
| Prepayments and accrued income | 53.39 | 82.38 | 59.19 | 39.06 | 26.52 |
| Current other receivables | 9.04 | 19.00 | 27.00 | 25.59 | 39.07 |
| Current deferred tax assets | 7.81 | 11.19 | |||
| Short term receivables total | 1 432.16 | 1 561.13 | 3 252.89 | 1 569.69 | 1 793.39 |
| Cash and bank deposits | 509.69 | 155.16 | 540.69 | 370.54 | 419.52 |
| Cash and cash equivalents | 509.69 | 155.16 | 540.69 | 370.54 | 419.52 |
| Balance sheet total (assets) | 3 045.65 | 3 553.42 | 5 978.58 | 3 990.23 | 5 768.25 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 600.00 | 500.00 | |||
| Retained earnings | 113.85 | 191.47 | - 431.46 | - 315.21 | 257.06 |
| Profit of the financial year | 77.62 | -22.93 | 616.25 | 572.27 | -92.95 |
| Shareholders equity total | 271.47 | 248.54 | 864.79 | 837.06 | 244.11 |
| Provisions | 2.05 | ||||
| Non-current other liabilities | 57.73 | 156.00 | 159.18 | 158.57 | 167.32 |
| Non-current liabilities total | 57.73 | 156.00 | 159.18 | 158.57 | 167.32 |
| Current trade creditors | 379.44 | 55.89 | 40.19 | 37.83 | 53.13 |
| Current owed to participating | 9.42 | 0.30 | 2.28 | 2.60 | |
| Current owed to group member | 612.54 | 313.29 | 892.21 | 12.64 | 2 824.26 |
| Short-term deferred tax liabilities | 25.74 | 165.70 | 173.61 | 5.75 | |
| Other non-interest bearing current liabilities | 1 689.31 | 2 779.69 | 3 856.22 | 2 768.23 | 2 469.02 |
| Current liabilities total | 2 716.45 | 3 148.88 | 4 954.62 | 2 994.59 | 5 354.76 |
| Balance sheet total (liabilities) | 3 045.65 | 3 553.42 | 5 978.58 | 3 990.23 | 5 768.25 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.